This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovasculardisease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.
The Society’s EDGES ( Early-Career Development Grant for Echo Scientists ) research program is intended to fund projects that address a clinical gap in cardiovascular ultrasound imaging through research directed by an early career scientist or investigator. Three recipients were each awarded a $25,000 grant.
Background With the rapid development of technology, artificial intelligence (AI) has been widely used in the diagnosis and prognosis prediction of a variety of diseases, including cardiovasculardisease. Facts have proved that AI has broad application prospects in rapid and accurate diagnosis.
mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovasculardisease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.
Sign Me Up 1 2022: The Year in CardiovascularDisease – The Year of Upfront Lipid Lowering Combination Therapy. 2 JACC: CardiovascularImaging May 2015, 8 (5) 579-596; We would love to see you there, but if you cannot make it live, the recording will be available to everyone who registers. 2022;18(6).
Christian Tesche (Division of CardiovascularImaging, Department of Radiology and Radiological Science, Medical University of South Carolina and Department of Cardiology, Munich University Clinic, Ludwig-Maximilian-University).
Cleerly’s pioneering approach to advanced cardiovascularimaging, powered by AI-driven analysis, is elevating the field of diagnostic tools for coronary artery disease. As we’ve seen with their recent Medicare and CPT I code approvals, this technology is both valuable and ready today in the fight against heart disease.”
mtaschetta-millane Tue, 07/16/2024 - 09:59 July 16, 2024 — Arineta , a leader in advancing cardiovascularimaging solutions through cutting-edge technology, proudly announces the latest installation of its SpotLight Duo at Cardiovascular Consultants, Ltd. (CVC) CVC) in Arizona. sec per rotation.
In the pursuit of enhancing cardiovascular care, medical research and advanced imaging techniques stand at the forefront. The establishment of CardiovascularImaging Research & Core Labs marks a pivotal leap in medical landscape, promising groundbreaking advancements and fostering innovation in cardiovascular health.
In the pursuit of enhancing cardiovascular care, medical research and advanced imaging techniques stand at the forefront. The establishment of CardiovascularImaging Research & Core Labs marks a pivotal leap in medical landscape, promising groundbreaking advancements and fostering innovation in cardiovascular health.
Within the complex umbrella of cardiovasculardisease, CAD is a type of heart disease that develops when the coronary arteries narrow and the heart cannot deliver enough oxygen-rich blood to the heart.
This theme will highlight the role of cardiovasculardisease in the broader scope of global health. This year organizers will be integrating EuroEcho-Imaging, ICNC-CT, and EuroCMR, so that the event preserves each discipline’s unique strengths while fostering a unified vision of patient-centered, multimodal care.
Subscribe now 1 Risk of Premature CardiovascularDisease vs the Number of Premature Cardiovascular Events. EuropeanHeartJournal-CardiovascularImaging(2020)21,1177–1183 3 Association of Normal Systolic Blood Pressure Level With CardiovascularDisease in the Absence of Risk Factors. JAMA Cardiol. JAMA Cardiol.
Circulation: CardiovascularImaging, Volume 17, Issue 2 , Page e016409, February 1, 2024. Innovations in cardiac imaging have fundamentally advanced the understanding and treatment of cardiovasculardisease.
Circulation: CardiovascularImaging, Volume 17, Issue 2 , Page e015712, February 1, 2024. BACKGROUND:Coronary artery calcium computed tomography (CAC) is an important tool for identifying subclinical atherosclerosis and cardiovascular risk stratification.
Circulation: CardiovascularImaging, Ahead of Print. It is well understood that cancer therapies including chemotherapy, tyrosine kinase inhibitors, immune checkpoint inhibitors, and radiation can increase the risk of cardiovasculardisease in patients with cancer.
Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.
However, it is not clear to what extent chronic cardiovascular dysfunction might mediate these functional impairments, or how we might screen and manage these patients at risk of chronic cardiovasculardisease. Studies examining cardiovascular outcomes or symptoms following an episode of sepsis in adults were included.
Circulation: CardiovascularImaging, Ahead of Print. Nevertheless, the factors underlying the effect of lipid-lowering therapy on disease regression remain poorly characterized. BACKGROUND:Intensive lipid-lowering therapy may induce coronary atherosclerosis regression.
Circulation: CardiovascularImaging, Ahead of Print. BACKGROUND:The development of thoracic aortic calcium (TAC) temporally precedes coronary artery calcium more often in women versus men.
Circulation: CardiovascularImaging, Ahead of Print. BACKGROUND:Coronary artery calcium (CAC) scoring predicts cardiovascular risk, but social determinants of health may play a role in its prognostic ability. SVI was determined for each participant based on the census tract.
Circulation: CardiovascularImaging, Ahead of Print. Higher annual increase rates in ICI users were consistent across several anatomic landmarks, preexisting cardiovasculardisease status, arterial calcification status, and concomitant chemotherapy or steroid use. In ICI users, [18F]FDG uptake increased by 2.5%
Morris, MD: Board-certified in internal medicine, cardiovasculardiseases, cardiac computed tomography, and clinical lipidology. Morris leads its Seinsheimer Cardiovascular Health Program and is co-director of MUSC Women’s Heart Care. Brittany Weber MD, Ph.D.:
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content